secwatch.observer — SEC 8-K summary
======================================

Issuer:     EXAGEN INC. (XGN)
CIK:        0001274737
Form:       8-K
Filed at:   2022-01-10T23:59:59+00:00
Accession:  0001274737-22-000003
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Exagen provides AVISE RADR presentation; no material operational or financial news
--------------------------------------------------------------------------------

- Exagen released updated investor presentation highlighting its AVISE RADR test for rheumatoid arthritis drug response.
- Presentation dated January 10, 2022, focuses on the test's ability to predict drug response in RA patients.
- Company did not disclose any new financial results, guidance, or material events.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1274737/000127473722000003/0001274737-22-000003-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1274737/000127473722000003/exdx-20220110.htm
  HTML page:      https://secwatch.observer/filing/0001274737-22-000003

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer